Chris Ryan
Gilead Sciences (NASDAQ:GILD) has reportedly settled a patent lawsuit with the federal government over its HIV drugs Truvada and Descovy.
The lawsuit stemmed from research Gilead (NASDAQ:GILD) conducted with the U.S. Centers for Disease Control and Prevention to see if
